Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Grasela

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Medical Clinics of North America|January 13, 2001
Antimicrobial pharmacodynamicsP G Ambrose, R C Owens, D Grasela
Journal of Clinical Pharmacology|December 31, 2013
Randomized, placebo-controlled single-ascending-dose study to evaluate the safety, tolerability and pharmacokinetics of the HIV nucleoside reverse transcriptase inhibitor, BMS-986001, in healthy subjectsY Urata, E Paintsil, Y-C Cheng, et al.
Cancer Research|July 15, 1995
Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualinK Dhingra, H Fritsche, J L Murray, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Medical Clinics of North America|January 13, 2001
Antimicrobial pharmacodynamicsP G Ambrose, R C Owens, D Grasela
Journal of Clinical Pharmacology|December 31, 2013
Randomized, placebo-controlled single-ascending-dose study to evaluate the safety, tolerability and pharmacokinetics of the HIV nucleoside reverse transcriptase inhibitor, BMS-986001, in healthy subjectsY Urata, E Paintsil, Y-C Cheng, et al.
Cancer Research|July 15, 1995
Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualinK Dhingra, H Fritsche, J L Murray, et al.
Pageof 1